Cefmetazole Sodium is an antibiotic that belongs to the cephalosporin class, functioning specifically as a beta-lactam antibiotic. It is marketed under various trade names such as Cefmetazole, Cefmetazon, and Cefmetazone. Originally developed in Japan by
Yamanouchi Pharmaceutical Co., Ltd., which is now part of
Astellas Pharma, it has since been researched and produced by various pharmaceutical companies around the globe. The drug is primarily used in clinical settings for its broad-spectrum antibacterial activity, effectively targeting several Gram-negative and Gram-positive bacteria. Indications for Cefmetazole Sodium include the treatment of
respiratory tract infections,
urinary tract infections,
skin and soft tissue infections, and
abdominal infections. Research indicates that it has also shown promise in combating certain drug-resistant bacterial strains, positioning it as an important weapon in the fight against antimicrobial resistance.
Cefmetazole Sodium works by inhibiting bacterial cell wall synthesis. Like other beta-lactam antibiotics, it binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall.
PBPs play a critical role in the cross-linking process of peptidoglycan chains, which are essential components of the bacterial cell wall structure. By binding to these proteins, Cefmetazole Sodium disrupts the synthesis of the cell wall, leading to the formation of weak points and eventually causing bacterial cell lysis and death. This mechanism of action is effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms, making it a highly versatile antibiotic option.
Cefmetazole Sodium is typically administered via intravenous or intramuscular injection, ensuring rapid absorption and distribution throughout the body. The recommended dosage depends on the type and severity of the
infection, as well as the patient’s medical condition and response to treatment. Generally, for adults, the dosage ranges from 1 to 2 grams, administered every 8 to 12 hours. The onset of action is relatively quick; patients can expect to see signs of improvement within 24 to 48 hours of the initial dose. However, it is crucial to complete the entire prescribed course of the antibiotic to avoid the risk of relapse or the development of antibiotic-resistant bacteria.
While Cefmetazole Sodium is highly effective, it is not without its side effects. Common side effects include gastrointestinal disturbances such as
nausea,
vomiting, and
diarrhea. Some patients may also experience
skin rashes,
itching, or
allergic reactions. More severe but less common side effects can include hematological issues such as
thrombocytopenia (low platelet count),
leukopenia (low white blood cell count), and
neutropenia (a specific type of low white blood cell count). In rare cases, it can cause hepatotoxicity, manifesting as elevated liver enzymes or
jaundice. Contraindications for the use of Cefmetazole Sodium include known hypersensitivity to cephalosporins or any of the excipients in the formulation. Patients with a history of severe allergic reactions to penicillins should also avoid this drug due to the potential for cross-reactivity. It is essential to consult with a healthcare provider to review the patient’s medical history and any possible allergic reactions before starting treatment with Cefmetazole Sodium.
Several drugs can interact with Cefmetazole Sodium, potentially altering its efficacy or increasing the risk of adverse effects. For example, concurrent use of aminoglycoside antibiotics may enhance the nephrotoxic effects, increasing the risk of kidney damage. Similarly, the co-administration of diuretics like
furosemide can also elevate the risk of
nephrotoxicity. Anticoagulants such as
warfarin may have their effects potentiated when used alongside Cefmetazole Sodium, necessitating close monitoring of blood coagulation parameters. Additionally,
probenecid, a drug used to treat
gout, can increase the plasma concentration of Cefmetazole Sodium by decreasing its renal clearance, potentially leading to toxicity. As with any medication, it is imperative to inform the healthcare provider of all other drugs and supplements being taken to avoid potentially harmful interactions.
In summary, Cefmetazole Sodium is a potent and versatile cephalosporin antibiotic used to treat a variety of
bacterial infections. Its mechanism of action involves the inhibition of bacterial cell wall synthesis, resulting in the effective eradication of both Gram-positive and Gram-negative bacteria. Administered via injection, it offers rapid onset of action, typically within 24 to 48 hours. However, it is essential to be aware of its potential side effects and contraindications, as well as possible drug interactions that may affect its efficacy or safety. Given its broad-spectrum activity and proven effectiveness, Cefmetazole Sodium remains a valuable option in the antibiotic arsenal, particularly in the context of growing antimicrobial resistance. Proper medical consultation and adherence to prescribed guidelines are crucial for maximizing the benefits while minimizing the risks associated with its use.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


